Core Insights - Hawkins, Inc. reported record sales, gross margin, operating income, EPS, and adjusted EBITDA for fiscal year 2025, marking a continued growth trajectory with a focus on sustained performance [4][5][7]. Fourth Quarter Fiscal Year 2025 Highlights - Fourth quarter sales reached $245.3 million, a 10% increase from the same quarter last year, driven by a 21% growth in the Water Treatment segment [5][8]. - Gross profit for the fourth quarter was $52.2 million, up 15% year-over-year, contributing to an operating income of $24.6 million, a 22% increase [5][7]. - Diluted EPS for the fourth quarter was $0.78, an 18% increase compared to the prior year [5][7]. - Adjusted EBITDA for the fourth quarter was $36.7 million, reflecting an 18% increase from the same period last year [5][16]. Full-Year Fiscal Year 2025 Highlights - Total annual sales were $974.4 million, a 6% increase from the previous fiscal year, with the Water Treatment segment achieving a 23% sales growth [5][9]. - Annual gross profit reached $225.5 million, a 16% increase year-over-year, leading to an operating income of $119.2 million, a 15% increase [5][10]. - Record diluted EPS for the year was $4.03, which is $0.44 or 12% higher than fiscal 2024 [5][7]. - Adjusted EBITDA for the full year was $167.5 million, a 17% increase from fiscal 2024 [5][16]. Executive Commentary - The CEO highlighted the company's disciplined M&A strategy, contributing to the growth of the Water Treatment segment, which is now the largest segment [4]. - The company completed four acquisitions during the fiscal year and has made a total of 13 acquisitions over the last five years [4]. - Looking ahead, the company anticipates revenue to exceed $1 billion for the first time in its history in fiscal 2026, with expectations for EPS growth, albeit at a slower rate due to increased interest and amortization expenses [4][6]. Financial Performance - The Water Treatment segment generated $446.5 million in sales for the year, a 23% increase from $363.3 million in the previous year [9]. - The Industrial segment saw a decline in sales to $382.5 million, down 7% from $409.5 million [9]. - Health and Nutrition segment sales were $145.5 million, a slight decrease of 1% from the previous year [9]. Balance Sheet and Cash Flow - At the end of fiscal 2025, the company reported net debt of $143.9 million with a leverage ratio of 0.86x adjusted EBITDA [5][18]. - Operating cash flow for the year was $111.1 million, with significant investments in acquisitions and capital expenditures [5][18]. - The company paid cash dividends of $0.70 per share, marking the 40th consecutive year of dividend payments, reflecting an 11% increase over the prior year [5][18].